CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents	$ 549	$ 686
Accounts receivable, net of allowance for credit losses of $29 and $27 as of December 31, 2024 and 2023, respectively	1,304	1,210
Inventories	188	190
Prepaid expenses and other current assets	351	286
Total current assets	2,392	2,372
Property, plant and equipment, net	2,113	1,816
Operating lease right-of-use assets	651	602
Goodwill	8,856	7,733
Intangible assets, net	1,763	1,166
Investments in equity method investees	123	135
Other assets	255	198
Total assets	16,153	14,022
Current liabilities:
Accounts payable and accrued expenses	1,394	1,359
Less: Current portion of long-term debt	602	303
Current portion of long-term operating lease liabilities	173	153
Total current liabilities	2,169	1,815
Long-term debt	5,615	4,410
Long-term operating lease liabilities	535	503
Other liabilities	938	876
Commitments and contingencies
Redeemable noncontrolling interest	83	76
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2024 and 2023; 162 shares issued as of both December 31, 2024 and 2023	2	2
Additional paid-in capital	2,361	2,320
Retained earnings	9,360	8,825
Accumulated other comprehensive loss	(88)	(14)
Treasury stock, at cost; 51 shares as of both December 31, 2024 and 2023	(4,857)	(4,826)
Total Quest Diagnostics stockholders’ equity	6,778	6,307
Noncontrolling interests	35	35
Total stockholders’ equity	6,813	6,342
Total liabilities and stockholders’ equity	$ 16,153	$ 14,022